Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

43.93
Delayed Data
As of Jul 26
 +1.62 / +3.83%
Today’s Change
33.50
Today|||52-Week Range
115.39
-32.33%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Higgons John Duncan
Chief Operating Officer
Sale8/17/201520,000$92.24$1.8M-54.31%
Higgons John Duncan
Chief Operating Officer
Sale9/15/201520,000$91.11$1.8M-52.35%
Biller Scott
Chief Scientific Officer
Sale6/08/201627,500$65.00$1.8M-33.53%
Higgons John Duncan
Chief Operating Officer
Sale10/15/201520,000$71.04$1.4M-42.51%
Higgons John Duncan
Chief Operating Officer
Sale11/16/201520,000$61.51$1.2M-25.71%
Higgons John Duncan
Chief Operating Officer
Sale12/15/201520,000$50.09$1.0M-13.06%
Schenkein David Paul
Chief Executive Officer
Sale8/03/20158,000$110.60$884.8K-60.39%
Biller Scott
Chief Scientific Officer
Sale8/10/20155,500$100.00$550.0K-55.92%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale9/24/20156,000$85.97$515.8K-48.76%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale9/24/20154,856$88.89$431.6K-48.76%
Page of 10